Related Experiment Videos
Hyperinsulinemia in hepatic steatosis
International Journal of Obesity
|January 1, 1982
Summary
Hepatic steatosis, or fatty liver disease, is linked to relative insulin resistance. This study found impaired glucose tolerance and altered metabolic markers in patients with fatty liver.
Area of Science:
- Metabolic Disorders
- Hepatology
- Endocrinology
Background:
- Hepatic steatosis (fatty liver disease) is a growing health concern.
- Understanding its metabolic implications, particularly insulin resistance, is crucial.
Purpose of the Study:
- To investigate glucose metabolism and hormonal profiles in patients with hepatic steatosis.
- To assess the relationship between hepatic steatosis and insulin resistance.
Main Methods:
- Evaluated blood glucose, insulin, C-peptide, free fatty acids (FFA), and growth hormone (HGH) in 45 patients with hepatic steatosis.
- Administered a 100g oral glucose load to assess glucose tolerance.
- Compared results to control groups where applicable.
Main Results:
- 59% of patients exhibited impaired glucose tolerance.
- Significantly elevated fasting and post-load levels of blood glucose, insulin, C-peptide, and FFA were observed.
- A reduced C-peptide/insulin ratio post-glucose administration suggested impaired hepatic insulin degradation.
Conclusions:
- Hepatic steatosis is associated with relative insulin resistance, potentially exacerbated by elevated FFA.
- Impaired hepatic insulin degradation may occur in hepatic steatosis.
- Metabolic derangements were consistent across different body weights and disease severity stages.